NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.
Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain
Published
Author(s)
Wei-Li Liao, Gun-Young Heo, Nathan G. Dodder, Rachel Reem, Natalia Mast, Suber Huang, Pier L. DiPatre, Illarion Turko, Irina A. Pikuleva
Abstract
Improper cholesterol metabolism in the brain causes neurological diseases. Factors affecting cholesterol homeostasis includes cholesterol hydroxylation reactions, which are regulated by cytochrome P450 enzymes. One approach to estimate the total enzymatic activity of the P450s is to measure the absolute protein concentration in the tissue. An optimized workflow, specifically developed for the quantification of membrane proteins, was used to measure the amount of three P450s, CYP7A1, CYP27A1, and CYP46A1, in the temporal lobe of four individual human brains. The quantification was performed using LC-MS/MS in MRM mode, in combination with nitrogen-15 labeled intact protein standards. We determined the absolute concentration of CYP27A1 and CYP46A1 in human brain; the concentration of CYP7A1 was less than the detection limit of 0.02 pmol/mg total protein. The average CYP27A1 expression level was around 0.1 pmol/mg total protein. The CYP27A1 expression level was identical between the gray and the white brain matter; in contrast the concentration of CYP46A1 was around 1.6-fold higher in the gray matter. The biological significance of this difference requires further investigation. This membrane protein quantification method was reproducible, with CVs from 5% to 25%; therefore, this approach is potentially capable of robust measurements in a clinical setting. The method described here can be expanded to include the quantification of other membrane proteins, for a more complete understanding of the role of P450s in human brain cholesterol homeostasis.
Liao, W.
, Heo, G.
, Dodder, N.
, Reem, R.
, Mast, N.
, Huang, S.
, DiPatre, P.
, Turko, I.
and Pikuleva, I.
(2011),
Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain, Journal of Proteome Research, [online], https://doi.org/10.1021/pr1008898
(Accessed October 10, 2025)